Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference80 articles.
1. Breast Cancer Statistics, 2022;Giaquinto;CA Cancer J Clin,2022
2. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018
3. Comprehensive molecular portraits of human breast tumours;Nature,2012
4. The 2019 World Health Organization classification of tumours of the breast;Tan;Histopathology,2020
5. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update;Allison;J Clin Oncol,2020
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11
2. Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression;Molecular Oncology;2024-06-12
3. Trastuzumab deruxtecan in breast cancer;Critical Reviews in Oncology/Hematology;2024-06
4. Systemic Therapy in Breast Cancer;American Society of Clinical Oncology Educational Book;2024-06-01
5. Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer;Biomedicines;2024-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3